Carbognilumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Carbognilumab, covering 2024-03-26 to 2024-04-02. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC) [Phase 2]